Matthias Philipp Müller

29PUBLICATIONS
52CO-AUTHORS
Proteomics and intermolecular interactions (excl. medical proteomics)Signal transductionMolecular targetsBiomolecular modelling and designGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Sep 29, 2026
Covalent-Allosteric Akt Inhibitors: Targeting Akt3 through Molecular Hybridization and Expanding the Isoform-Selective Toolbox.

|Sep 07, 2026
Isoform-Selective Targeting of Akt Through Covalent Allosteric Inhibition.

|Aug 06, 2026
Structure-based scaffold hopping reveals strategies to overcome oncogenic KIT and PDGFRA mutation-driven drug-resistance in GIST.

|Mar 02, 2026
Lessons from Structural Biology for Understanding Drug Resistance in Gastrointestinal Stromal Tumors (GIST).

Giorgia Mancino, Tom Schulz, Andrea Scrima

|May 29, 2025
Computational Design of Lysine Targeting Covalent Binders Using Rosetta.

Barr Tivon, Jan Wiese, Matthias P Müller

|May 14, 2025
Advancing TET Inhibitor Development: From Structural Insights to Biological Evaluation.

Suzanne Willems, Lejla Maksumic, Janina Niggenaber

Pageof 5

Frequent Collaborators

22 joint publications

Daniel Rauh

7 joint publications

Jörn Weisner

6 joint publications

Tom Schulz

6 joint publications

Roger S Goody